{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-200857","form_type":"8-K","ticker":"BDSX","cik":"0001439725","company_name":"BIODESIX INC","filed_at":"2024-08-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.076933+00:00","generated_at":"2026-05-31T08:59:26.118834+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Biodesix posts updated corporate presentation with no new financial or operational data","bullets":["Presentation filed under Item 7.01 and available on IR website.","Company describes itself as a blood-based lung diagnostic firm addressing large unmet need.","No specific financial figures, guidance, or clinical updates were disclosed.","Presentation contains no material new information beyond general business description."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-200857","json":"https://secwatch.observer/filing/0001193125-24-200857.json","markdown":"https://secwatch.observer/filing/0001193125-24-200857.md","text":"https://secwatch.observer/filing/0001193125-24-200857.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1439725/000119312524200857/0001193125-24-200857-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1439725/000119312524200857/d881327d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T08:59:26.118834+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}